Skip to main content
. 2025 Jun 17;18(7):sfaf189. doi: 10.1093/ckj/sfaf189

Figure 3:

Figure 3:

Depiction of uEV markers for different cell types of the urinary tract. Depicted are markers for bladder and prostate (a), renal pelvis (b), tubule system and juxtaglomerular apparatus (c) and the glomerulus (d). PPAP, prostatic acid phosphatase; TGM4, prostate transglutaminase; PSMA, prostate-specific membrane antigen; ACE, angiotensin-converting enzyme; APN, aminopeptidase N; URAT1, urate transporter 1; SGLT2, sodium/glucose cotransporter 2; CA IV, carbonic anhydrase, NHE3, Na+/H+ exchanger isoform 3; NCC, thiazide‐sensitive Na‐Cl cotransporter; AQP2, aquaporin 2; V-ATPase, vacuolar-type H+-ATPase; AQP1, aquaporin-1; UMOD/THP, uromodulin/Tamm–Horsfall protein; NKCC2, Na‐K‐2Cl cotransporter; SLC14A2, Solute Carrier Family 14 Member 2; EGFR, epidermal growth factor receptor; β-1 AR, beta-adrenergic receptor-1; SM22-α, smooth muscle 22 alpha; α8 integrin, alpha-8 integrin; WT-1, Wilms’ tumor 1; CR1, complement receptor 1; TRCP6, canonical transient receptor potential 6.